Status:
COMPLETED
Does Tailored Education in Asthma Care Help Improve Patient Satisfaction, Adherence, and Quality of Life (TEACH) Trial
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The primary purpose of this study is to assess whether tailored patient education for patients on Symbicort® Turbuhaler® therapy improves patient satisfaction, adherence and Quality of Life.
Eligibility Criteria
Inclusion
- Patients with the diagnosis of asthma.
- Patients with asthma, where the use of Symbicort® Turbuhaler® is indicated and would have been prescribed by the investigator as part of usual care.
- Patient who have public or private insurance coverage for Symbicort® Turbuhaler® or are willing to pay for this medication for the duration of the trial.
Exclusion
- Patients who have been treated wth Symbicort® Turbuhaler® in the preceding 3 months.
- A history of smoking \[i.e., 10 pack-years where one pack-year equals one pack (20 cigarettes) per day for one year, or equivalent\].
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00687310
Start Date
December 1 2005
End Date
January 1 2007
Last Update
January 24 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.